As of May 31, 2026, Neogen Corporation carries a market capitalization of 1.95B, placing it among publicly traded companies globally. Its enterprise value stands at 2.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.95B |
| Enterprise Value | 2.56B |
Neogen Corporation's next confirmed earnings release is scheduled for January 14, 2027.
| Earnings Date | 1/14/2027 |
As of May 31, 2026, Neogen Corporation has 217.70M shares outstanding.
| Shares Outstanding | 217.70M |
These figures are as of May 31, 2026. The price-to-sales ratio is 2.24, and the price-to-book ratio stands at 0.93.
| PS Ratio | 2.24 |
| PB Ratio | 0.93 |
| P/TBV Ratio | -7.17 |
| P/FCF Ratio | 61.18 |
| P/OCF Ratio | 23.46 |
As of May 31, 2026, Neogen Corporation trades at an EV/EBITDA multiple of 25.55 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.94 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.56B versus a market cap of 1.95B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 2.94 |
| EV / EBITDA | 25.55 |
As of May 31, 2026, Neogen Corporation maintains a current ratio of 3.82, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.92, indicating elevated leverage, while an interest coverage ratio of 1.70 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.82 |
| Quick Ratio | 2.10 |
| Debt / Equity | 37.92 |
| Debt / EBITDA | 7.92 |
| Interest Coverage | 1.70 |
Over the twelve months ended May 31, 2026, Neogen Corporation posted a negative return on equity (ROE) of -0.38, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.23, reflecting losses generated across the asset base. The company generates approximately 301,221.66 in revenue per employee across its workforce of 2,889.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.76 indicates how many times Neogen Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -0.38 |
| Return on Assets (ROA) | -0.23 |
| Revenue Per Employee | 301,221.66 |
| Employee Count | 2,889.50 |
| Inventory Turnover | 2.76 |
Over the twelve months ended May 31, 2026, Neogen Corporation recorded an income tax benefit of -1.07M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -8.96M and -7.89M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -1.07M |
As of the close on October 22, 2026, Neogen Corporation's stock has gained approximately 95.11% over the past 52 weeks. The 50-day moving average sits at 12.18, while the 200-day moving average is 10.33.
| 52-Week Price Change | 95.11% |
| 50-Day Moving Average | 12.18 |
| 200-Day Moving Average | 10.33 |
Over the twelve months ended May 31, 2026, Neogen Corporation generated 870.38M in revenue and converted that into -7.89M in net income, yielding earnings per share of -0.04. EBITDA reached 100.23M, while operating income came in at -21.67M.
| Revenue | 870.38M |
| Gross Profit | 408.45M |
| Operating Income | -21.67M |
| Pretax Income | -8.96M |
| Net Income | -7.89M |
| EBITDA | 100.23M |
| EBIT | -21.67M |
| Earnings Per Share (EPS) | -0.04 |
As of May 31, 2026, Neogen Corporation holds 185.50M in cash and equivalents against 793.70M in total debt, resulting in a net debt position of 608.20M. Total book value stands at 2.09B, with working capital of 446.40M providing operational flexibility.
| Cash & Cash Equivalents | 185.50M |
| Total Debt | 793.70M |
| Net Debt | 608.20M |
| Equity (Book Value) | 2.09B |
| Book Value Per Share | 9.61 |
| Working Capital | 446.40M |
Neogen Corporation produced 83.20M in operating cash flow over the twelve months ended May 31, 2026. After subtracting -51.30M in capital expenditures, free cash flow totaled 31.90M - equivalent to 0.15 per share.
| Operating Cash Flow | 83.20M |
| Capital Expenditures | -51.30M |
| Free Cash Flow | 31.90M |
| FCF Per Share | 0.15 |
Over the twelve months ended May 31, 2026, Neogen Corporation posted a gross margin of 46.93, reflecting its pricing power and cost economics. The operating margin of -2.49 and net profit margin of -0.91 provide insight into operational efficiency.
| Gross Margin | 46.93 |
| Operating Margin | -2.49 |
| Pretax Margin | -1.03 |
| Profit Margin | -0.91 |
| EBITDA Margin | 11.52 |
These figures cover the twelve months ended May 31, 2026. Free cash flow yield stands at 1.63, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 5.09, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Neogen Corporation shareholders.
| Shareholder Yield | 5.09 |
| FCF Yield | 1.63 |
Neogen Corporation's most recent stock split took place on June 7, 2021 with a 1:2 split ratio.
| Last Split Date | 6/7/2021 |
| Split Ratio | 1:2 |
As of May 31, 2026, Neogen Corporation has an Altman Z-Score of 1.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.52 |